Dr. Bhagirathbhai Dholaria’s area of specialization is in the treatment of hematological malignancies and stem cell transplantation. His primary field of research is in the use of adoptive cellular therapies for the treatment of relapsed lymphoid and plasma cell malignancies.
Dr. Dholaria has conducted studies investigating the outcomes of non-Hodgkin lymphoma patients undergoing chimeric antigen receptor T-cell (CAR-T) therapies and is involved in translational research investigating the biomarkers of CAR T-cell therapy-associated toxicities. He has also conducted several observational studies utilizing cancer registries to study outcomes of mature T-cell lymphoma patients and presented his findings in national meetings. He has won the ASCO Conquer Cancer Foundation Merit award for his work.
Dr. Dholaria’s clinical interests include non-Hodgkin lymphoma, multiple myeloma, acute and chronic leukemias, adoptive cellular therapy (CAR-T), and stem cell transplantation.